Turlo Agnieszka J, Cywinska Anna, Frisbie David D
Department of Pathology and Veterinary Diagnostics, Warsaw University of Life Sciences, ul. Nowoursynowska 159c, 02-776, Warsaw, Poland.
Gail Holmes Equine Orthopaedic Research Center, Colorado State University, 300 West Drake Road, Fort Collins, CO, 80523, USA.
BMC Vet Res. 2019 Feb 26;15(1):66. doi: 10.1186/s12917-019-1799-7.
High prevalence of musculoskeletal disorders in racehorses and its impact on horse welfare and racing economics call for improved measures of injury diagnosis and prevention. Serum biomarkers of bone and cartilage metabolism have previously shown promise in prediction of musculoskeletal injuries in horses. This study aimed to re-evaluate usability of the predictive serum biomarkers identified in North American Thoroughbred racehorses in a geographically distinct group of Polish Thoroughbreds.
Serum concentrations of bone and cartilage biomarkers: osteocalcin, c-terminal telopeptide of type I collagen, total glycosaminoglycans (GAG), chondroitin sulfate epitope and c-propeptide of type II procollagen (CPII) were evaluated in the beginning and the next 3 months of one racing season in a cohort of twenty-six 2-year-old Polish racehorses. Exit criteria were diagnosis of musculoskeletal injury, leading to > 5 days off training (n = 8), or completion of 3 study months with no training interruptions (n = 18). Normalized results and matching archival data from 35 2-year-old North American racehorses was used for logistic regression analysis to identify universal predictors of injury. Mean GAG and CPII levels were lower in injured group comparing to control, which is consistent with previous findings in racehorses. These biomarkers were also identified as predictors of injury in the mixed population model. Population origin had no significant effect on predictive value of evaluated biomarkers (Wald test p = 0.137). Decreased osteocalcin and increased c-terminal telopeptide of type I collagen levels in injured horses comparing to controls were specific for Polish population and signalized disruption in bone turnover homeostasis.
Changes in serum GAG and CPII in racehorses at risk of injury appear to be similar across distinct populations while dynamics of serum bone marker is more population-specific.
赛马中肌肉骨骼疾病的高发病率及其对马匹福利和赛马经济的影响,要求改进损伤诊断和预防措施。骨和软骨代谢的血清生物标志物此前已显示出预测马匹肌肉骨骼损伤的潜力。本研究旨在重新评估在北美纯种赛马中鉴定出的预测性血清生物标志物在地理位置不同的波兰纯种马群体中的可用性。
在一个由26匹2岁波兰赛马组成的队列中,在一个赛马赛季开始时以及接下来的3个月内,评估了骨和软骨生物标志物的血清浓度:骨钙素、I型胶原c末端肽、总糖胺聚糖(GAG)、硫酸软骨素表位和II型前胶原c前肽(CPII)。退出标准为诊断为肌肉骨骼损伤,导致训练中断超过5天(n = 8),或完成3个研究月且无训练中断(n = 18)。来自35匹2岁北美赛马的标准化结果和匹配的存档数据用于逻辑回归分析,以确定损伤的通用预测指标。与对照组相比,受伤组的平均GAG和CPII水平较低,这与之前在赛马中的研究结果一致。在混合群体模型中,这些生物标志物也被确定为损伤的预测指标。种群来源对评估的生物标志物的预测价值没有显著影响(Wald检验p = 0.137)。与对照组相比,受伤马匹的骨钙素降低和I型胶原c末端肽水平升高是波兰种群特有的,表明骨转换稳态受到破坏。
不同种群中,有受伤风险的赛马血清GAG和CPII的变化似乎相似,而血清骨标志物的动态变化更具种群特异性。